Dotinurad Uses, Dosage, Side Effects and more
Dotinurad is under investigation in clinical trial NCT03372200 (Febuxostat-controlled, Double-blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout).
| Trade Name | Dotinurad |
| Generic | Dotinurad |
| Dotinurad Other Names | Dotinurad |
| Type | |
| Formula | C14H9Cl2NO4S |
| Weight | Average: 358.19 Monoisotopic: 356.9629343 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
